|
Market Cap (4-Jun) $35,464,388 (1,259th) |
Close (30-Jun) $0.080 |
Volume (30-Jun) 244,049 |
Shortsold (15-Jan) 38,875 (0.01%) (540th) |
|
52w High $0.260 |
52w Low $0.054 |
P/E - |
EPS -0.02 |
NSB released this announcement to the ASX on 11 November 2021, 12:56. The announcement is not marked as price sensitive, and is 16 page(s) in length and 1.14MB in size.
You can view all announcements from NSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, NSB was 0.012% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (15 January 2026).
| Other Recent Announcements from NSB | |
|---|---|
| Change of Director's Interest Notice - Rennie | 7 June 2023, 8:22 |
| Change of Director's Interest Notice - Uvarov | 25 May 2023, 15:30 |
| Change of Director's Interest Notice - Rennie | 25 May 2023, 15:07 |
| Chairman's Address to Shareholders | 11 November 2021, 12:56 |
| NSB Partners with Biospective for MS Studies | 2 November 2021, 8:39 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 October 2021, 18:38 |
| Company Presentation - updated | 26 October 2021, 17:49 |
You must be logged in to post a reply.
NeuroScientific Biopharmaceuticals 